(Q48617573)

13 February 2018

title

Analysis of 34 candidate genes in bupropion and placebo remission. (English)

1 reference

13 February 2018

1 reference

4

Tamara Arenovich

1 reference

13 February 2018

Clement C. Zai

2

0 references

James L. Kennedy

6

0 references

Daniel J. Müller

5

0 references

author name string

Arun K Tiwari

1

1 reference

13 February 2018

Gautam Sajeev

3

1 reference

13 February 2018

publication date

4 September 2012

1 reference

13 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

13 February 2018

volume

16

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

771-781

1 reference

13 February 2018

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

How placebos change the patient's brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

MAOA and the neurogenetic architecture of human aggression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

The placebo-reward hypothesis: dopamine and the placebo effect

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Pharmacogenetics of antidepressant response: an update

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

A genomewide association study of citalopram response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

An assessment of the utility of single nucleotide polymorphisms (SNPs) for forensic purposes

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Pharmacogenomics of antidepressant drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Reward and the serotonergic system

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Changes in brain function of depressed subjects during treatment with placebo

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

The functional neuroanatomy of the placebo effect

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Bupropion increases striatal vesicular monoamine transport

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Meta-analysis of the placebo response in antidepressant trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Genetic predictors of response to antidepressants in the GENDEP project

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

Accurate, Large-Scale Genotyping of 5HTTLPR and Flanking Single Nucleotide Polymorphisms in an Association Study of Depression, Anxiety, and Personality Measures

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712000843

7 January 2021

10.1017/S1461145712000843

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

22947179

1 reference

13 February 2018